Cargando…
The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed
Randomized trials supporting the benefit of endovascular treatment in acute ischemic stroke patients with a large early infarction are not yet available. Few retrospective studies exist that suggest a potential positive treatment effect on functional outcome, as well as procedural safety. However, p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795604/ https://www.ncbi.nlm.nih.gov/pubmed/35095708 http://dx.doi.org/10.3389/fneur.2021.718046 |
_version_ | 1784641105739907072 |
---|---|
author | Broocks, Gabriel Meyer, Lukas McDonough, Rosalie Bechstein, Matthias Hanning, Uta Fiehler, Jens Kemmling, Andre |
author_facet | Broocks, Gabriel Meyer, Lukas McDonough, Rosalie Bechstein, Matthias Hanning, Uta Fiehler, Jens Kemmling, Andre |
author_sort | Broocks, Gabriel |
collection | PubMed |
description | Randomized trials supporting the benefit of endovascular treatment in acute ischemic stroke patients with a large early infarction are not yet available. Few retrospective studies exist that suggest a potential positive treatment effect on functional outcome, as well as procedural safety. However, potential benefit or harm of MT in patients with low initial ASPECTS is still a subject of current debate, and in particular, how to select these patients for treatment. The purpose of this pilot study was to evaluate how early tissue water uptake in acute ischemic brain might determine lesion fate and functional outcome in low ASPECTS patients undergoing MT. We observed that the degree of early water uptake measured by quantitative NWU was significantly associated with functional outcome in low ASPECTS patients, yielding a higher diagnostic power compared to other parameters such as ASPECTS, age, or NIHSS. No conclusive evidence of a beneficial effect of successful reperfusion was observed in patients with low ASPECTS and high NWU, which highlights the potential of NWU as a tool to specify patient selection. |
format | Online Article Text |
id | pubmed-8795604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87956042022-01-29 The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed Broocks, Gabriel Meyer, Lukas McDonough, Rosalie Bechstein, Matthias Hanning, Uta Fiehler, Jens Kemmling, Andre Front Neurol Neurology Randomized trials supporting the benefit of endovascular treatment in acute ischemic stroke patients with a large early infarction are not yet available. Few retrospective studies exist that suggest a potential positive treatment effect on functional outcome, as well as procedural safety. However, potential benefit or harm of MT in patients with low initial ASPECTS is still a subject of current debate, and in particular, how to select these patients for treatment. The purpose of this pilot study was to evaluate how early tissue water uptake in acute ischemic brain might determine lesion fate and functional outcome in low ASPECTS patients undergoing MT. We observed that the degree of early water uptake measured by quantitative NWU was significantly associated with functional outcome in low ASPECTS patients, yielding a higher diagnostic power compared to other parameters such as ASPECTS, age, or NIHSS. No conclusive evidence of a beneficial effect of successful reperfusion was observed in patients with low ASPECTS and high NWU, which highlights the potential of NWU as a tool to specify patient selection. Frontiers Media S.A. 2022-01-14 /pmc/articles/PMC8795604/ /pubmed/35095708 http://dx.doi.org/10.3389/fneur.2021.718046 Text en Copyright © 2022 Broocks, Meyer, McDonough, Bechstein, Hanning, Fiehler, Kemmling https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Broocks, Gabriel Meyer, Lukas McDonough, Rosalie Bechstein, Matthias Hanning, Uta Fiehler, Jens Kemmling, Andre The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed |
title | The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed |
title_full | The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed |
title_fullStr | The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed |
title_full_unstemmed | The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed |
title_short | The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray—What Current Trials May Have Missed |
title_sort | benefit of thrombectomy in patients with low aspects is a matter of shades of gray—what current trials may have missed |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795604/ https://www.ncbi.nlm.nih.gov/pubmed/35095708 http://dx.doi.org/10.3389/fneur.2021.718046 |
work_keys_str_mv | AT broocksgabriel thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT meyerlukas thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT mcdonoughrosalie thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT bechsteinmatthias thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT hanninguta thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT fiehlerjens thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT kemmlingandre thebenefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT broocksgabriel benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT meyerlukas benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT mcdonoughrosalie benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT bechsteinmatthias benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT hanninguta benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT fiehlerjens benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed AT kemmlingandre benefitofthrombectomyinpatientswithlowaspectsisamatterofshadesofgraywhatcurrenttrialsmayhavemissed |